128 related articles for article (PubMed ID: 6195340)
1. Circulating complement fixing immune complexes in chronic hepatitis. Use of anti-C3 enzyme immunoassay to define antibody class and nature of antigen.
Sagnelli E; Felaco FM; Triolo G; Vernace SJ; Filippini P; Piccinino F; Behrens U; Paronetto F
J Clin Lab Immunol; 1983 Sep; 12(1):11-5. PubMed ID: 6195340
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
[TBL] [Abstract][Full Text] [Related]
3. Incidence of antibodies against rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
Ortona L; Laghi V; Tamburrini E; Troncone L; Bonifazi N; Nervo P; Cauda R
Clin Exp Immunol; 1983 May; 52(2):437-40. PubMed ID: 6861379
[TBL] [Abstract][Full Text] [Related]
4. Arthritis associated with chronic active hepatitis: complement activation and characterization of circulating immune complexes.
Wands JR; Alpert E; Isselbacher KJ
Gastroenterology; 1975 Dec; 69(6):1286-91. PubMed ID: 1193327
[TBL] [Abstract][Full Text] [Related]
5. Characterization of antigen moiety of HBsAg in the complement fixing immune complexes of hepatitis B virus positive chronic active hepatitis.
Gupta RC
Clin Exp Immunol; 1982 Sep; 49(3):543-51. PubMed ID: 7172494
[TBL] [Abstract][Full Text] [Related]
6. The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes.
Wands JR; Mann E; Alpert E; Isselbacher KJ
J Clin Invest; 1975 May; 55(5):930-6. PubMed ID: 1123429
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic reactivity of the skin in chronic hepatitis].
Fuchs H
Ann Acad Med Stetin; 1990; 36():61-75. PubMed ID: 2099109
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific detection of HBsAG-containing immune complexes in the course of hepatitis B virus infection.
Pernice W; Sodomann CP; Lüben G; Seiler FR; Sedlacek HH
Clin Exp Immunol; 1979 Aug; 37(2):376-80. PubMed ID: 91465
[TBL] [Abstract][Full Text] [Related]
9. The IgG antibody reactivity of sera from patients with active chronic hepatitis to a crude liver antigen and liver specific protein (LSP): analysis by ELISA and immunoblotting.
Sundin U; Heigl Z; Sundqvist KG
Clin Exp Immunol; 1988 Nov; 74(2):276-82. PubMed ID: 3265656
[TBL] [Abstract][Full Text] [Related]
10. LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?
Meyer zum Büschenfelde KH; Manns M; Hütteroth TH; Hopf U; Arnold W
Clin Exp Immunol; 1979 Aug; 37(2):205-12. PubMed ID: 498582
[TBL] [Abstract][Full Text] [Related]
11. Studies on experimental chronic active hepatitis in the rabbit. II. Immunological findings.
Butler RC
Br J Exp Pathol; 1984 Aug; 65(4):509-19. PubMed ID: 6432031
[TBL] [Abstract][Full Text] [Related]
12. Antigen-specific detection of HBsAg-containing immune-complexes in sera from chronic active hepatitis patients with hepatitis B virus persistent infection by enzyme-immunoassay (EIA).
Tsuji T; Araki K; Tsuchiya M; Nagashima H; Naito K
Gastroenterol Jpn; 1980; 15(6):606-8. PubMed ID: 6161054
[TBL] [Abstract][Full Text] [Related]
13. Immunological studies in HBV-related chronic liver diseases.
Joshi N; Ayesha Q; Habibullah CM
Indian J Pathol Microbiol; 1990 Oct; 33(4):351-4. PubMed ID: 2132503
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
[TBL] [Abstract][Full Text] [Related]
15. Studies on anti-liver cell membrane antibodies in sera of patients with autoimmune chronic active hepatitis.
Morito T; Sato K; Mukai S; Takagi T; Saito K; Nishimaki T; Kasukawa R
Fukushima J Med Sci; 1989 Dec; 35(2):61-8. PubMed ID: 2487313
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lymphocyte cytotoxicity in chronic active hepatitis.
Kakumu S; Hara T; Gohji H; Sakamoto N
Clin Exp Immunol; 1978 Jul; 33(1):71-8. PubMed ID: 709913
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients.
Brown SE; Howard CR; Steward MW; Ajdukiewicz AB; Whittle HC
Clin Exp Immunol; 1984 Feb; 55(2):355-9. PubMed ID: 6199140
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune implications of immune complexes in clinical variants of hepatitis B.
Daugharty H; Kelley K; Moore C; Hersh T
Clin Exp Immunol; 1979 Aug; 37(2):213-20. PubMed ID: 498583
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes in hepatitis B: levels, immunoglobulin class of antibody and the presence of hepatitis B surface antigen.
Brown SE; Howard CR; Steward MW; Viola L; Murray-Lyon IM
Dev Biol Stand; 1983; 54():391-7. PubMed ID: 6653894
[TBL] [Abstract][Full Text] [Related]
20. Circulating and tissue-bound immune complexes in allergic vasculitis: relationship between immunoglobulin class and clinical features.
Kauffmann RH; Herrmann WA; Meijer CJ; Daha MR; Vanes LA
Clin Exp Immunol; 1980 Sep; 41(3):459-70. PubMed ID: 7438561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
